Type 2 & other diabetes

Different roles of protein biomarkers predicting estimated glomerular filtration rate (eGFR) trajectories in people with chronic kidney disease and diabetes mellitus: a nationwide retrospective cohort study

Cardiovasc DiabetolPublished Retrospective cohort study

Authors' conclusion

Protein biomarkers only modestly improve predictive accuracy compared to clinical predictors alone. The different protein markers serve different roles for the prediction of longitudinal eGFR trajectories potentially reflecting their role in the disease pathway.

Study context

Population
People with DM and moderately advanced chronic kidney disease (CKD), nationwide German Chronic Kidney Disease study
Participants
838 people
Exposure
Clinical + protein predictors model vs clinical only model
Outcome
Prediction of eGFR trajectories (predictive accuracy)
Methodological detailsnationwide, Bayesian linear mixed models, repeated cross-validation
  • Nationwide
  • Bayesian linear mixed models
  • Repeated cross-validation

Main finding

As reported in the abstract

Predictive performance for eGFR trajectories

Combined model [Formula] before updating by baseline eGFR

0.44

95% CrI 0.37–0.50

Combined model [Formula] after updating by baseline eGFR

0.59

95% CrI 0.51–0.65

Observational data: associations, not effects.

Further findings

Roles of individual predictors

Few predictors sufficient for performance comparable to main model
TNF Receptor 1 and Receptor for Advanced Glycation Endproducts associated with baseline eGFR
Kidney Injury Molecule 1 and urine albumin-creatinine-ratio predictive for future eGFR decline

Original publication

Different roles of protein biomarkers predicting eGFR trajectories in people with chronic kidney disease and diabetes mellitus: a nationwide retrospective cohort study. Cardiovasc Diabetol. Published 29 March 2023. doi:10.1186/s12933-023-01808-5

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.